IRF2BPL: A new genotype for progressive myoclonus epilepsies
Abstract
The progressive myoclonus epilepsies (PMEs) are a heterogeneous group of neurodegenerative disorders, typically presenting in late childhood. An etiologic diagnosis is achieved in about 80% of patients with PME, and genome‐wide molecular studies on remaining, well‐selected, undiagnosed cases can further dissect the underlying genetic heterogeneity. Through whole‐exome sequencing (WES), we identified pathogenic truncating variants in the IRF2BPL gene in two, unrelated patients presenting with PME. IRF2BPL belongs to the transcriptional regulators family and it is expressed in multiple human tissues, including the brain. Recently missense and nonsense mutations in IRF2BPL were found in patients presenting with developmental delay and epileptic encephalopathy, ataxia, and movement disorders, but none with clear PME. We identified 13 other patients in the literature with myoclonic seizures and IRF2BPL variants. There was no clear genotype–phenotype correlation. With the description of these cases, the IRF2BPL gene should be considered in the list of genes to be tested in the presence of PME, in addition to patients with neurodevelopmental or movement disorders.Keywords
Funding Information
- Ministero della Salute (SG‐2018‐12368345)
- National Health and Medical Research Council (APP1196637)
This publication has 14 references indexed in Scilit:
- Progressive myoclonus epilepsies—Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genesThe American Journal of Human Genetics, 2021
- IRF2BPL mutation causes nigrostriatal degeneration presenting with dystonia, spasticity and keratoconusParkinsonism & Related Disorders, 2020
- IRF2BPL gene variants: One new caseAmerican Journal of Medical Genetics Part A, 2019
- IRF2BPL mutations cause autosomal dominant dystonia with anarthria, slow saccades and seizuresParkinsonism & Related Disorders, 2019
- IRF2BPL gene mutation: Expanding on neurologic phenotypesAmerican Journal of Medical Genetics Part A, 2019
- Neurodevelopmental disorder associated with IRF2BPL gene mutation: Expanding the phenotype?Parkinsonism & Related Disorders, 2019
- IRF2BPL Is Associated with Neurological PhenotypesThe American Journal of Human Genetics, 2018
- A novel MED12 mutation: Evidence for a fourth phenotypeAmerican Journal of Medical Genetics Part A, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Classification of progressive myoclonus epilepsies and related disordersAnnals of Neurology, 1990